Jumat, 04 Mei 2012

Lyrica (pregabalin) No Good For Diabetes Or HIV Associated Neuropathic Pain

Lyrica (pregabalin) No Good For Diabetes Or HIV Associated Neuropathic Pain

Editor's Choice
Main Category: Pain / Anesthetics
Also Included In: Diabetes;  HIV / AIDS
Article Date: 04 May 2012 - 14:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions   <!-- rate icon rate article



Patient / Public:not yet rated

Healthcare Prof:3 stars

3 (1 votes)


Lyrica (pregabalin) failed in two separate human trials to reduce neuropathic pain linked to diabetes or HIV, said makers Pfizer today. One of the trials - Phase III HIV neuropathy - was stopped early because no benefits were found in an interim analysis on 246 patients out of a planned 416.

The other study, also a placebo-controlled Phase III trial, involving 665 individuals, looked at Lyrica for peripheral diabetic neuropathy (second-line therapy). Other treatments had been ineffective.

The participants were switched to pregabalin (single-blind) for a period of six, and then randomly selected to be administered either more pregabalin or placebo for a further 13 weeks (double blind).

The patients on pregabalin did improve from baseline to the end of the trial period. However, there was not a significant difference when compared to the placebo - on a standard 10-point scale the difference was 3.9 versus 3.5.

Pregabalin is approved as first-line treatment for diabetic neuropathy, fibromyalgia, partial onset seizures, and postherpetic neuralgia.

Steven J. Romano, M.D., senior vice president, Head, Medicines Development Group, Global Primary Care Business Unit, Pfizer Inc., said:

"The results of this study show the complexities of studying pain, particularly in a difficult-to-treat condition such as neuropathic pain associated with HIV neuropathy for which there are no approved medications in the United States.

The study of Lyrica for this condition is an example of Pfizer's dedication to better understanding neuropathic pain and to providing data and developing treatments to address areas of patient need."

What is neuropathic pain

Neuropathic pain is chronic pain caused by a nervous system injury. The injury may be in the brain or spinal cord (central nervous system) or nerves outside the spinal cord or brain (peripheral nervous system).

Neuropathic pain can be the result of trauma and many diseases, such as multiple sclerosis, diabetes, HIV, and stroke.

Neuropathic pain affects approximately 2 million people in the USA. It is often very hard to treat properly.

Written by Christian Nordqvist


Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Please use one of the following formats to cite this article in your essay, paper or report:

MLA


APA

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Lyrica (pregabalin) No Good For Diabetes Or HIV Associated Neuropathic Pain'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



MediLexicon International Ltd Logo

Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.

Everyday Health Network

Tidak ada komentar:

Posting Komentar